- $2.58bn
- $2.63bn
- $9.68m
Brief: Precigen Reports Q4 And FY 2022 Financial Results And Business Updates
Precigen Inc expected to post a loss of 10 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Hess Corp, Monro, MarketAxess
U.S. STOCKS ON THE MOVE-Block Inc, Fennec, Inhibikase Therapeutics
U.S. STOCKS ON THE MOVE-Canoo, Microsoft, Boeing
Precigen tumbles on pricing $75 mln stock offering
Brief: Precigen Announces Pricing Of $75.0 Million Public Offering Of Common Stock
Brief: Precigen Announces Positive Early Stage Data In Patients With Recurrent Respiratory Papillomatosis
Brief: Precigen Announces Proposed $75.0 Million Public Offering Of Common Stock
Precigen drops after $75 mln equity offering launch
Precigen Inc reports results for the quarter ended in September - Earnings Summary
Brief: Precigen Reports Third Quarter 2022 Financial Results
Precigen Inc expected to post earnings of 2cents a share - Earnings Preview
Precigen Inc expected to post earnings of 2cents a share - Earnings Preview
Brief: Precigen Names Rutul R. Shah Chief Operating Officer
Brief: Precigen Says Co Entered Into A Controlled Equity Offering Sales Agreement
Precigen Inc reports results for the quarter ended in June - Earnings Summary
Brief: Precigen Reports Second Quarter And First Half 2022 Financial Results
Brief: Precigen Reported On Ruling Of Arbitration Panel In Pending Arbitration Matter Involving Co, Investors In Intrexon Energy Partners